TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21085591

Group type: EXPERIMENTAL
Intervention: MVA-CMDR (10^8 pfu IM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: MVA-CMDR (10^7 pfu IM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: MVA-CMDR (10^6 pfu ID)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 17525774

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with hyaluronidase 15 IU/ml
Number of subjects: 19

Group type: COMPARATOR
Intervention: Lidocaine 2% alone (control)
Number of subjects: 19
Study: 16148817

Group type: EXPERIMENTAL
Intervention: Temporal artery thermometer
Number of subjects: 44

Group type: COMPARATOR
Intervention: Pulmonary artery catheter
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Axillary thermometer
Number of subjects: 44
Study: 12660058

Group type: EXPERIMENTAL
Intervention: VIT (venom immunotherapy)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo to VIT crossover
Number of subjects: 68
Study: 10385577

Group type: EXPERIMENTAL
Intervention: Young subjects (n = 32)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Elderly subjects (n = 20)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 8543545

Group type: EXPERIMENTAL
Intervention: Three-times-weekly, bilateral, brief pulse ECT
Number of subjects: 47

Group type: COMPARATOR
Intervention: Twice-weekly ECT plus one simulated treatment per week
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both ECT groups
Number of subjects: 47
Study: 1988388

Group type: EXPERIMENTAL
Intervention: One Step Skin Prep used once
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ECG Prep Pad used once
Number of subjects: 120

Group type: COMPARATOR
Intervention: ECG Prep Pad used five times
Number of subjects: 120
Study: 6285450

Group type: EXPERIMENTAL
Intervention: pivmecillinam/pivampicillin
Number of subjects: 23

Group type: COMPARATOR
Intervention: pivmecillinam alone
Number of subjects: 23
Study: 30908587

Group type: EXPERIMENTAL
Intervention: Sevoflurane at end tidal concentration of 1.32% ± 1.0%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane at end tidal concentration of 2% for 4 minutes before cannulation attempt
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane concentration adjusted using Dixon and Massey up and down method
Number of subjects: 0
Study: 30041145

Group type: EXPERIMENTAL
Intervention: Anodal tsDCS (2.5 mA, 15 min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cathodal tsDCS (2.5 mA, 15 min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham tsDCS (15 min)
Number of subjects: 14
Study: 27185843

Group type: EXPERIMENTAL
Intervention: Trabectedin 1.1 mg/m² plus Doxorubicin 60 mg/m²
Number of subjects: 115

Group type: COMPARATOR
Intervention: Doxorubicin 75 mg/m²
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Trabectedin plus Doxorubicin
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: FAS and p53 expression
Number of subjects: 115
Study: 24607844

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation Therapy (SMT)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Exercise Therapy (high dose, supervised low-tech trunk exercise)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Short course of home exercise and self-care advice
Number of subjects: 199
Study: 22417189

Group type: EXPERIMENTAL
Intervention: New Beginnings Program
Number of subjects: 240
Study: 18091486

Group type: EXPERIMENTAL
Intervention: McKenzie treatment
Number of subjects: 260

Group type: COMPARATOR
Intervention: Strengthening training
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 260
Study: 15034503

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study: 11489238

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9552779

Group type: EXPERIMENTAL
Intervention: Incisional morphine (5 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (5 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine (5 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall morphine and acetaminophen consumption
Number of subjects: 46
Study: 7925214

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.9 mg kg‐1
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pancuronium 0.085 mg kg‐1
Number of subjects: 26
Study: 2973531

Group type: EXPERIMENTAL
Intervention: Plasma-derived hepatitis B virus vaccine
Number of subjects: 186

Group type: COMPARATOR
Intervention: DNA recombinant hepatitis B virus vaccine
Number of subjects: 186
Study: 791318

Group type: EXPERIMENTAL
Intervention: Intramuscular metoclopramide before effervescent aspirin
Number of subjects: 2

Group type: COMPARATOR
Intervention: Effervescent aspirin alone
Number of subjects: 2
Study: 27325207

Group type: EXPERIMENTAL
Intervention: 3-month gender-targeted weight loss program
Number of subjects: 159
Study: 26403639

Group type: EXPERIMENTAL
Intervention: MiStent SES
Number of subjects: 149

Group type: COMPARATOR
Intervention: Endeavor
Number of subjects: 149
Study: 24584055

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral treatment (ICBT) with systematic exposure to IBS symptoms and related situations
Number of subjects: 309

Group type: COMPARATOR
Intervention: Internet-delivered cognitive behavioral treatment without systematic exposure (ICBT‐WE)
Number of subjects: 309
Study: 21648015

Group type: EXPERIMENTAL
Intervention: Early palliative care intervention
Number of subjects: 469

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 469
Study: 20178877

Group type: EXPERIMENTAL
Intervention: Active acupressure treatments
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo acupressure treatments
Number of subjects: 16
Study: 19031154

Group type: EXPERIMENTAL
Intervention: Nonsequential presentation of time, number, and length
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential presentation of number and length
Number of subjects: 0
Study: 16477953

Group type: EXPERIMENTAL
Intervention: Tiagabine 4 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Tiagabine 8 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tiagabine 2 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12735531

Group type: EXPERIMENTAL
Intervention: Occupational therapy aimed at ADL activities
Number of subjects: 309

Group type: COMPARATOR
Intervention: Leisure therapy
Number of subjects: 309
Study: 10653675

Group type: EXPERIMENTAL
Intervention: Optimum ST elevation model (based on > or =1 mm ST elevation in > or = 1 inferior/lateral leads, or > or =2 mm ST elevation in > or =1 anteroseptal leads)
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Different definitions of 'significant' ST elevation
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Multiple QRST variables in addition to ST elevation
Number of subjects: 1190
Study: 8885736

Group type: EXPERIMENTAL
Intervention: Ritodrine tocolysis (111 micrograms/min)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Ritodrine tocolysis in nulliparous patients
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo in nulliparous patients
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Ritodrine tocolysis in parous subjects
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo in parous subjects
Number of subjects: 283
Study: 1906447

Group type: EXPERIMENTAL
Intervention: Psyllium preparation (5 ml, 3 times a day for 6 days)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 6408016

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (200 kcal) with T3 supplementation (150 micrograms daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-calorie diet (200 kcal) without T3 supplementation (control group)
Number of subjects: 18
Study: 30666783

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atosiban
Number of subjects: 0
Study: 26980547

Group type: EXPERIMENTAL
Intervention: Acupuncture plus usual care
Number of subjects: 233

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 233
Study: 25396263

Group type: EXPERIMENTAL
Intervention: Clinical monitoring of ART
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Continuing cotrimoxazole prophylaxis
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Restricting routine CD4 monitoring to after 52 weeks following ART initiation
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Restricting routine CD4 monitoring to after 52 weeks following ART initiation for older children (12+ years)
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Continued provision of cotrimoxazole
Number of subjects: 1206

Group type: COMPARATOR
Intervention: Routine laboratory monitoring
Number of subjects: 1206
Study: 24444271

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy
Number of subjects: 60
Study: 23171524

Group type: EXPERIMENTAL
Intervention: Patient-oriented treatment decision aid (PORTDA-diab) offered immediately before quarterly practice consultation.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (Control group).
Number of subjects: 0
Study: 20044662

Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention training for CMHTs (12 hours of training)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Enhanced relapse prevention training for CMHTs
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 96
Study: 17545705

Group type: EXPERIMENTAL
Intervention: Vicriviroc 10 mg twice a day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vicriviroc 25 mg twice a day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vicriviroc 50 mg twice a day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16334931

Group type: EXPERIMENTAL
Intervention: Flexible spiral drains (Blake silicon drains, Ethicon)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard chest drains (Dahlausen GmbH)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both drain types
Number of subjects: 28
Study: 12069671

Group type: EXPERIMENTAL
Intervention: Early statin therapy (median, 2.0 days after ACS; n = 3952)
Number of subjects: 12365

Group type: COMPARATOR
Intervention: No statin therapy (n = 8413)
Number of subjects: 12365

Group type: EXPERIMENTAL
Intervention: Early statin therapy
Number of subjects: 12365

Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 12365
Study: 9859922

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae DNA detection in atherosclerotic samples
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae DNA detection in coronary revascularization samples
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae DNA detection in carotid artery stenosis samples
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae DNA detection in aorta samples
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae DNA detection in iliac artery samples
Number of subjects: 238

Group type: COMPARATOR
Intervention: Non-atherosclerotic control samples
Number of subjects: 238
Study: 7622969

Group type: EXPERIMENTAL
Intervention: Clear communication instructions (n = 30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Unclear communication instructions (n = 31)
Number of subjects: 61
Study: 2883104

Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 and 0.2 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: S 3341 (1 and 2 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Clonidine and S 3341
Number of subjects: 10
Study: 31977878

Group type: EXPERIMENTAL
Intervention: Multicomponent treatment program for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional treatment for 12 weeks
Number of subjects: 56
Study: 30564798

Group type: COMPARATOR
Intervention: Direct restoration with composite (C)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Direct restoration with composite and additional glass‐fiber post (CP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ceramic veneer restoration (V)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ceramic veneer restoration and additional glass‐fiber post (VP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ceramic crown restoration (Cr)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ceramic crown restoration and additional glass‐fiber post (CrP)
Number of subjects: 72
Study: 27484173

Group type: EXPERIMENTAL
Intervention: Simple Calculation and Reading Aloud intervention (SCRA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 0
Study: 24954843

Group type: EXPERIMENTAL
Intervention: Cortisol administration (20mg intravenously) before retrieval
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cortisol administration before encoding
Number of subjects: 0
Study: 22215031

Group type: EXPERIMENTAL
Intervention: Lingual exercise targeting strength
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lingual exercise targeting endurance
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lingual exercise targeting power
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lingual exercise targeting speed
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 25
Study: 20394322

Group type: EXPERIMENTAL
Intervention: C-Flex (dip level 2)
Number of subjects: 76

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: C-Flex
Number of subjects: 76
Study: 18212283

Group type: EXPERIMENTAL
Intervention: Buflomedil
Number of subjects: 2078

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2078
Study: 18821106

Group type: EXPERIMENTAL
Intervention: Direct therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indirect therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual levels of community‐based speech‐and‐language therapy
Number of subjects: 0
Study: 15353155

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) treatment for 1-4 weeks
Number of subjects: 2793
Study: 11810350

Group type: EXPERIMENTAL
Intervention: TENS SM1AKS 80 Hz 6 mA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo TENS SM1AKS 80 Hz 0 mA
Number of subjects: 30
Study: 9250304

Group type: EXPERIMENTAL
Intervention: 5% acetic acid applied before the smear
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (acetic acid applied after the smear)
Number of subjects: 42
Study: 8326055

Group type: EXPERIMENTAL
Intervention: Circuit weight training for 4 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 43
Study: 3826809

Group type: EXPERIMENTAL
Intervention: Oral phenytoin capsules (18 mg/kg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oral phenytoin suspension (18 mg/kg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oral phenytoin (both forms)
Number of subjects: 44
Study: 977729

Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30730214

Group type: EXPERIMENTAL
Intervention: Free-of-charge subdermal etonogestrel implant (SEI)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Partially paid subdermal etonogestrel implant (SEI)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Free-of-charge and partially paid subdermal etonogestrel implant (SEI)
Number of subjects: 265
Study: 28349730

Group type: EXPERIMENTAL
Intervention: CHO (7.5% CHO; 5 mL · kg‐1 per exercise session; n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: PLA (0% CHO, taste- and volume-matched solution; n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 12

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO and PLA
Number of subjects: 12
Study: 26717860

Group type: EXPERIMENTAL
Intervention: LCPT (once daily at 0.17 mg/kg/d)
Number of subjects: 543

Group type: COMPARATOR
Intervention: IR-Tac (twice daily at 0.1 mg/kg/d)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: LCPT
Number of subjects: 543

Group type: COMPARATOR
Intervention: IR-Tac
Number of subjects: 543
Study: 25217464

Group type: EXPERIMENTAL
Intervention: Web-based cardiac rehabilitation program ('ActivateYourHeart') for 6 weeks.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 94
Study: 21671144

Group type: EXPERIMENTAL
Intervention: High frequency rTMS (20 Hz)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low frequency rTMS (1 Hz)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study: 20018274

Group type: EXPERIMENTAL
Intervention: Beta-blockers (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anxiolytics (Group 3)
Number of subjects: 60
Study: 18186583

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints selected by thermogram (temperature difference > 0.5 degrees C from healthy side)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Acupuncture at conventionally selected acupoints
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints selected by thermogram
Number of subjects: 180
Study: 15102874

Group type: EXPERIMENTAL
Intervention: 1.25 mg/day FTY720
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5 mg/day FTY720
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12226034

Group type: EXPERIMENTAL
Intervention: IV preparation (80 mg in 2 mL vial diluted with 2 mL saline containing preservatives)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Preservative-free preparation (300 mg in 5 mL solution)
Number of subjects: 19

Group type: COMPARATOR
Intervention: IV preparation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Preservative-free preparation
Number of subjects: 19
Study: 9839330

Group type: EXPERIMENTAL
Intervention: Oxygen administration before hepatic DSA
Number of subjects: 0
Study: 8205580

Group type: EXPERIMENTAL
Intervention: Colgate Platinum Professional Toothwhitening System
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rembrandt Lighten Bleaching Gel
Number of subjects: 50
Study: 2732125

Group type: EXPERIMENTAL
Intervention: Oral rifampicin 900 mg/day plus oral doxycycline 200 mg/day for 45 days (Regimen A)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Oral doxycycline 200 mg/day for 45 days plus im streptomycin 1 g/day for 21 days (Regimen B)
Number of subjects: 143

Group type: COMPARATOR
Intervention: WHO regimen combining oral tetracycline 2 g/day for 21 days plus im streptomycin 1 g/day for 14 days (Regimen C)
Number of subjects: 143
Study: 29713463

Group type: EXPERIMENTAL
Intervention: Zinc (303 children)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Placebo (301 children)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Zinc (121 children, subgroup)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Placebo (121 children, subgroup)
Number of subjects: 604
Study: 28954791

Group type: EXPERIMENTAL
Intervention: Mii-vitaliSe intervention (Nintendo Wii) for 12 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mii-vitaliSe intervention (Nintendo Wii) after a 6-month wait for 6 months
Number of subjects: 30
Study: 26159140

Group type: EXPERIMENTAL
Intervention: Silver-Care-Robot Program (conducted twice a week for 5 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 42
Study: 23180349

Group type: EXPERIMENTAL
Intervention: UFT/leucovorin/irinotecan (TEGAFIRI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: UFT/leucovorin/oxaliplatin (TEGAFOX)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Overall response
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Progression-free and overall survival
Number of subjects: 49
Study: 21600084

Group type: EXPERIMENTAL
Intervention: Combination therapy of compound azintamid (2 tablets 3 times a day) and domperidone (10 mg 3 times a day) for 4 weeks
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Combination therapy of compound azintamid and domperidone
Number of subjects: 208

Group type: COMPARATOR
Intervention: Domperidone (10 mg 3 times a day) for 4 weeks
Number of subjects: 208
Study: 18462076

Group type: EXPERIMENTAL
Intervention: Brief intervention aimed at reducing HIV-related stigma, conveyed through participatory small group activities (role-plays, games, group discussions, testimony by an HIV advocate).
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 138
Study: 16950470

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 22
Study: 12201926

Group type: EXPERIMENTAL
Intervention: 3-week dietary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostate biopsy trauma
Number of subjects: 0
Study: 10326889

Group type: EXPERIMENTAL
Intervention: LNG-containing oral contraceptive minipills (30 mirog)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: LNG-releasing intrauterine contraceptive system (LNG-IUS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Copper-releasing intrauterine device (IUD)
Number of subjects: 31
Study: 8953976

Group type: EXPERIMENTAL
Intervention: Macular scatter ('grid') laser photocoagulation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 103
Study: 1778327

Group type: EXPERIMENTAL
Intervention: JNIH-7 (mono-component vaccine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JNIH-6 (two-component vaccine)
Number of subjects: 0
Study: 7095559

Group type: EXPERIMENTAL
Intervention: prednisolone/azathioprine therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: no therapy (control group)
Number of subjects: 30